The groundbreaking therapy of this peptide represents a exciting development in the care of type 2 diabetes. Distinct from existing drugs, tirzepatide affects two pathways – GLP-1 and glucose-dependent insulinotropic https://tirzepatidepeptide797370.smblogsites.com/42105376/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment